| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 04/14/1999 | EP0767777B1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/14/1999 | CN1213564A Chinese medicinal pills for treating catarct and its prodn. method |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016755A1 Novel angiogenesis inhibitors |
| 04/08/1999 | CA2303830A1 Novel angiogenesis inhibitors |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | CN1213314A Improved vision through photodynamic therapy of eye |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5891884 Use of an imidazole derivative for preventing and/or treating rhinitis |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/01/1999 | WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015203A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 04/01/1999 | WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 04/01/1999 | WO1999014998A2 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 04/01/1999 | DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents |
| 04/01/1999 | CA2304647A1 Method for preventing and treating hearing loss using sensorineurotophic compounds |
| 04/01/1999 | CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | CA2304162A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2272605A1 Pharmaceutical composition containing gp34 binding-inhibitory agent as effective ingredient |
| 03/31/1999 | EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 03/31/1999 | EP0905249A2 Alcohol dehydrogenase |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
| 03/31/1999 | EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them |
| 03/31/1999 | EP0905126A1 Metalloproteinase inhibitors |
| 03/31/1999 | EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 03/31/1999 | EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE |
| 03/31/1999 | EP0904080A1 Inhibitors of farnesyl-protein transferase |
| 03/31/1999 | EP0904076A1 Inhibitors of farnesyl-protein transferase |
| 03/31/1999 | EP0904069A1 Pla2 inhibitors of angiogenesis |
| 03/31/1999 | EP0737185B1 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof |
| 03/31/1999 | CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 03/30/1999 | US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 03/30/1999 | US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists |
| 03/30/1999 | US5888771 Gene products as targets for the development of antibiotics. |
| 03/30/1999 | US5888770 Spoiiie |
| 03/30/1999 | CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts |
| 03/25/1999 | WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 03/25/1999 | WO1999013910A1 Neovascularization inhibitor |
| 03/25/1999 | WO1999013909A1 Corneal neovascularization inhibitors |
| 03/25/1999 | WO1999013885A1 Modulation of immune responses |
| 03/25/1999 | WO1999013863A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 03/25/1999 | WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/25/1999 | WO1998048027A3 Materials and methods for treatment of retinal diseases |
| 03/25/1999 | WO1998048009A3 Materials and methods for ribozyme treatment of retinal diseases |
| 03/25/1999 | CA2304119A1 Modulation of immune responses |
| 03/25/1999 | CA2244978A1 Novel alcohol dehydrogenase |
| 03/25/1999 | CA2244971A1 Mure |
| 03/24/1999 | EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them |
| 03/24/1999 | EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid |
| 03/24/1999 | EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 03/24/1999 | EP0902680A1 Reparation and prevention of fibrotic lesions |
| 03/24/1999 | EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 03/23/1999 | US5886179 Nucleotide analogs |
| 03/23/1999 | US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute |
| 03/23/1999 | US5886035 Difluoroprostaglandin derivatives and their use |
| 03/23/1999 | US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 03/23/1999 | US5885832 Human lens epithelial cell line |
| 03/23/1999 | US5885795 Methods of expressing angiostatic protein |
| 03/23/1999 | US5885572 Administering polypeptide or active fragment to treat bacterial infections |
| 03/23/1999 | CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them |
| 03/22/1999 | CA2244239A1 Novel era |
| 03/18/1999 | WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 03/18/1999 | WO1999012898A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 03/18/1999 | WO1999012896A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 03/18/1999 | WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 03/18/1999 | CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 03/18/1999 | CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 03/18/1999 | CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 03/17/1999 | EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones |
| 03/17/1999 | EP0901483A2 Benzofurans and benzopyrans as chronobiological agents |
| 03/17/1999 | EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 03/17/1999 | EP0901373A1 Alpha v Beta 3 ANTAGONISTS |
| 03/17/1999 | EP0819003A4 A method for the treatment of macular degeneration |
| 03/17/1999 | EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/17/1999 | EP0565634B1 Angiotensin ii receptor blocking compositions |
| 03/17/1999 | CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 03/17/1999 | CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 03/17/1999 | CN1211238A Benzimidazole derivatives |
| 03/17/1999 | CN1211186A Method of treating otitis media with uridine triphosphates and related compounds |
| 03/17/1999 | CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity |
| 03/17/1999 | CN1042539C 11,21-bisphenyl-19-norpregnane derivatives |
| 03/16/1999 | US5883239 aroA |